MindLight
Commercial- Indications
- Major Depressive Disorder
Company intelligence / Profile preview
Circular Genomics
Albuquerque, New Mexico, United Statescirculargenomics.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Circular Genomics has developed the first-ever circular RNA-based diagnostic test ("MindLight") to predict patient response to SSRI antidepressants in Major Depressive Disorder. Clinical studies show that baseline blood levels of a specific circRNA biomarker are nearly twice as high in nonresponders versus responders to sertraline, with strong statistical significance ((p < .0001), (n=110)). The company’s approach offers real-time insights into brain health and treatment responsiveness, aiming to transform precision psychiatry by reducing trial-and-error prescribing.
- Therapeutic areas
- PsychiatryNeurology
- Modalities
- Biomarkers (circular RNA)Diagnostic assays
- Industry
- Molecular Diagnostics
02
Drug pipeline
1 asset03
Partnerships
No major pharma partnerships disclosed as of latest updates. Open to partnering opportunities.
Beyond the preview
Go deeper on Circular Genomics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Circular Genomics.